52-Week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-Positive Chronic Hepatitis B

Background and Aims: The Roadmap concept is a therapeutic framework in chronic hepatitis B for the intensification of nucleoside analogue monotherapy based on early virologic response. The efficacy and safety of this approach applied to telbivudine treatment has not been investigated. Methods: A mul...

ver descrição completa

Detalhes bibliográficos
Autor principal: Piratvisuth, Teerha (author)
Outros Autores: Komolmit, Piyawat (author), Tanwandee, Tawesak (author), Sukeepaisarnjaroen, Wattana (author), Chan, Henry (author), Pessôa, Mário Guimarães (author), Fassio, Eduardo (author), Ono, Suzane Kioko (author), Bessone, Fernando (author), Daruich, Jorge (author), Zeuzem, Stefan (author), Cheinquer, Hugo (author), Pathan, Rashidkhan (author), Dong, Yuhong (author), Trylesinski, Aldo (author)
Formato: other article
Idioma:eng
Publicado em: 2019
Assuntos:
Antígenos E da Hepatite B
Hepatite B crônica
Texto completo:http://hdl.handle.net/10183/200470
País:Brasil
Oai:oai:www.lume.ufrgs.br:10183/200470

Texto Completo

http://hdl.handle.net/10183/200470

Registos relacionados